Navigation Links
Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2012 Financial Results on January 29th
Date:1/17/2013

NATICK, Mass., Jan. 17, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the fourth quarter and full year ended December 31st, 2012 on Tuesday, January 29th, at 8:00 a.m. ET.

The call will be hosted by Michael Mahoney , president and chief executive officer, and Jeff Capello , executive vice president and chief financial officer.

A live webcast of the conference call will be available via Boston Scientific's website.  Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors.  Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.

The webcast is also being distributed over Thomson Reuters Investor Distribution Network via two locations: www.earnings.com, which is accessible to the public, and www.streetevents.com, a password-protected event management site.

An archived replay of the webcast will be accessible at www.bostonscientific.com/investors approximately one hour following the completion of the conference call and available for approximately one year.

The company will issue a press release announcing financial results for the fourth quarter and full year 2012 on Tuesday, January 29th, prior to the conference call.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for mo
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration
2. Boston Childrens Hospital announces international genomics competition winner
3. BioBDx to Present at the 2012 BioPharm America and AdvaMed MedTech Conferences in Boston
4. Alacrita Establishes U.S. Headquarters in Boston Area
5. Sanofi Signs Agreement for Type 1 Diabetes Research with Boston Academic Teaching Hospital
6. Cadence Pharmaceuticals To Present At The Deutsche Bank Securities, Inc. 37th Annual Health Care Conference In Boston On May 8, 2012
7. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
8. Source Scientific LLC is 100% Acquired by BIT Analytical Instruments
9. MakeSigns.com Announces New Tri-Fold Scientific Poster Service
10. APAC Stem Cell Research & Therapy Market a “Growth Engine” for Region’s Scientific Ambitions Says A New Market Research Report at ReportsnReports.com
11. Provia Labs’ Store-A-Tooth™ Announces Top Expert in Stem Cell Biobanking as its Scientific Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... November 21, 2014 , ...   Mariano Rodríguez es elegid vicepresidente senior ... KLOX está en marcha para comenzar de forma rápida ... heridas de reciente aprobación en Europa   , ... complace al anunciar los siguientes nombramientos: Todd ...
(Date:11/21/2014)... Alto, Calif. (PRWEB) November 20, 2014 ... a nonprofit, public policy research organization representing leading ... pharmaceutical firms, and PwC US today ... states in life sciences industry growth. The trend ... 2013. The 2015 California Biomedical Industry Report ...
(Date:11/21/2014)... Texas (PRWEB) November 21, 2014 ... Sodium Ferrocyanide Industry” is a professional and in-depth ... provides Sodium ferrocyanide information, like its definition, ... as industry overview. This report covers the international ... as global (such as the US, Europe, Asia, ...
(Date:11/21/2014)... , Nov. 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" ... nine month periods ended September 30, 2014.  Biorem,s complete 2014 third ... www.sedar.com ). Financial Summary:Three-months ended September 30, ... per share data) , 2014 , 2013 ... 2,282 , 5,281 , 6,715 , ...
Breaking Biology Technology:KLOX Technologies anuncia sus nombramientos ejecutivos 2KLOX Technologies anuncia sus nombramientos ejecutivos 3KLOX Technologies anuncia sus nombramientos ejecutivos 4KLOX Technologies anuncia sus nombramientos ejecutivos 5California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 2California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 3California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 4Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 2Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 3Biorem Reports Third Quarter Results 2Biorem Reports Third Quarter Results 3
... Largest Pharmacy Distributor Introduces RESPeRATE Hypertension ... Treatment Device Into Country,s Retail Market, ... InterCure, Ltd. (TASE:,INCR), today announced that its RESPeRATE(R) ... significantly lower blood,pressure, will launch into retail distribution ...
... NEW YORK, Sept. 17 ,Microbia, Inc. and ... today announced,that they have entered into a ... and co-market Microbia,s first-in-class compound linaclotide.,Linaclotide is ... irritable bowel syndrome (IBS-C), chronic,constipation (CC), and ...
... 17 Mylan Laboratories Inc.,(NYSE: MYL ) ... announced cash tender offers and consent solicitations for ... (the "2010 Notes") and,6.375% Senior Notes due 2015 ... with the 2010 Notes, the "Notes"), which are ...
Cached Biology Technology:InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom 2InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom 3InterCure and Mashco Announce Launch into Independent Pharmacies in the United Kingdom 4Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration 2Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration 3Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration 4Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration 5Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 2Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 3
(Date:11/6/2014)... of metastasis, yet progress in preventing and treating ... been particularly challenging to design drugs that work ... systems biology at Harvard Medical School. , ... already metastasized." , Gujral and colleagues have now ... better understand how metastasis begins. Their findings may ...
(Date:11/5/2014)... Rio de Janeiro, Brazil -Individuals show great diversity in ... importantly, males and females greatly differ in their perceptual ... kinds of smell tests. , Sex differences ... social behaviors and may be connected to one,s perception ... and emotions. Thus, women,s olfactory superiority has been suggested ...
(Date:11/4/2014)... only marketing directed at children on the interior ... that the majority of black, middle-income and rural ... , Authored by Arizona State University researcher Punam ... first to examine the use of child-directed marketing ... restaurants and its relationship to demographics. It adds ...
Breaking Biology News(10 mins):Migration negation 2Migration negation 3The female nose always knows: Do women have more olfactory neurons? 2Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3
... their latest research findings at the 2011 Midwinter Meeting ... When: February 19-23, 2011 Where: Baltimore Marriott Waterfront ... be presented by scientists supported by the National Institute ... Deafness and the double helix: What ...
... Northwestern University scientists have discovered a new mechanism in ... loss of a certain gene, dubbed "twenty-four," messes up the ... harder for the flies to awaken. The circadian clock ... when it sleeps. While the Northwestern study was done using ...
... colonoscopies, including mice. University of Missouri researchers are ... to predict colon cancer caused by inflammation. A ... Diagnostic Laboratory (RADIL) could eventually lead to a ... working to develop novel therapeutics for colon cancer, ...
Cached Biology News:NIDCD research at ARO Midwinter Meeting 2NIDCD research at ARO Midwinter Meeting 3NIDCD research at ARO Midwinter Meeting 4NIDCD research at ARO Midwinter Meeting 5NIDCD research at ARO Midwinter Meeting 6NIDCD research at ARO Midwinter Meeting 7Waking up is hard to do 2MU researchers believe discovery could lead to testing that displaces colonoscopies 2
Agar, 500 g. Noble Agar.Moisture: < 10%, ash: < 1.6%, EEO (-mr): < 0.450 (pH 8.4). Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Ms anti-Cyclophilin D...
... Intended to qualitatively ... in formalin-fixed, paraffin-embedded (FFPE) ... spreads, and cell preparations, ... Hybridization (CISH). Fluorescent In ...
Mouse GM CSF Construction Kit provides antigen affinity purified polyclonal capture and tracer antibodies, and antigen standard for development of approximately ten microplate assays....
Biology Products: